Literature DB >> 11149975

Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction.

M A Blajchman1, M Goldman, J J Freedman, G D Sher.   

Abstract

Mesh：

Year:  2001        PMID： 11149975     DOI： 10.1053/tmrv.2001.19946

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN： 0887-7963


× No keyword cloud information.
  14 in total

Review 1.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

Review 2.  How we treat cytomegalovirus in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh; Per Ljungman
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

4.  Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis.

Authors:  Maria Agapova; Elzbieta Lachert; Ewa Brojer; Magdalena Letowska; Piotr Grabarczyk; Brian Custer
Journal:  Transfus Med Hemother       Date:  2015-04-16       Impact factor: 3.747

5.  Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions.

Authors:  Cassandra D Josephson; Marta-Inés Castillejo; Angela M Caliendo; Edmund K Waller; James Zimring; Kirk A Easley; Michael Kutner; Christopher D Hillyer; John D Roback
Journal:  Transfus Med Rev       Date:  2011-02-23

Review 6.  Transfusion medicine problems and solutions for the pediatric hematologist/oncologist.

Authors:  Naomi L C Luban; Eileen McBride; Jason C Ford; Sumit Gupta
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

7.  Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Authors:  R R Sharma; Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2010-01

Review 8.  Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents.

Authors:  Nicole Brenner; Anuhya Kommalapati; Muhammad Ahsan; Anirban Ganguli
Journal:  J Nephrol       Date:  2019-11-28       Impact factor: 3.902

9.  Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage.

Authors:  Grace Lim; Vladyslav Melnyk; Francesca L Facco; Jonathan H Waters; Kenneth J Smith
Journal:  Anesthesiology       Date:  2018-02       Impact factor: 7.892

Review 10.  Transfusion-transmitted infections.

Authors:  Florian Bihl; Damiano Castelli; Francesco Marincola; Roger Y Dodd; Christian Brander
Journal:  J Transl Med       Date:  2007-06-06       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.